- Report
- October 2025
- 97 Pages
Middle East
From €4205EUR$4,500USD£3,513GBP
- Report
- October 2025
- 84 Pages
Asia Pacific
From €4205EUR$4,500USD£3,513GBP
- Report
- October 2025
- 93 Pages
Kuwait
From €4205EUR$4,500USD£3,513GBP
- Report
- October 2025
- 88 Pages
Philippines
From €4205EUR$4,500USD£3,513GBP
- Report
- October 2025
- 86 Pages
Saudi Arabia
From €4205EUR$4,500USD£3,513GBP
- Report
- October 2025
- 82 Pages
Saudi Arabia
From €4205EUR$4,500USD£3,513GBP
- Report
- October 2025
- 90 Pages
Middle East
From €4205EUR$4,500USD£3,513GBP
- Report
- October 2025
- 81 Pages
Saudi Arabia
From €4205EUR$4,500USD£3,513GBP
- Report
- October 2025
- 86 Pages
Middle East
From €4205EUR$4,500USD£3,513GBP
From €4205EUR$4,500USD£3,513GBP
- Report
- October 2025
- 82 Pages
Middle East
From €4205EUR$4,500USD£3,513GBP
- Report
- October 2025
- 96 Pages
Japan
From €4205EUR$4,500USD£3,513GBP
- Report
- October 2025
- 80 Pages
Saudi Arabia
From €4205EUR$4,500USD£3,513GBP
- Report
- October 2025
- 98 Pages
Singapore
From €4205EUR$4,500USD£3,513GBP
- Report
- September 2025
- 97 Pages
Italy
From €4205EUR$4,500USD£3,513GBP
- Report
- September 2025
- 95 Pages
United States
From €4205EUR$4,500USD£3,513GBP
- Report
- September 2025
- 88 Pages
United Kingdom
From €4205EUR$4,500USD£3,513GBP
- Report
- June 2025
- 90 Pages
Global
From €4205EUR$4,500USD£3,513GBP
- Training
- April 2025
- 1 Day
Global
From €802EUR$859USD£670GBP
- Report
- February 2025
- 454 Pages
Global
From €4484EUR$4,799USD£3,746GBP

The Drug Discovery AI market is a rapidly growing sector of the pharmaceutical industry, focused on the development of artificial intelligence (AI) technologies to aid in the discovery of new drugs. AI-driven drug discovery is a process that uses machine learning algorithms to identify potential drug targets and develop new drug candidates. AI-driven drug discovery can reduce the time and cost of drug development, as well as improve the accuracy of drug discovery.
The Drug Discovery AI market is composed of a variety of companies, ranging from large pharmaceutical companies to small startups. Companies in the market include Atomwise, Exscientia, Insilico Medicine, and Recursion Pharmaceuticals. These companies are developing AI-driven drug discovery technologies to help accelerate the drug discovery process. Show Less Read more